Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-09-05 | New | $17,172,969 | Unknown | Other | SEC link | |
| 2025-01-31 | New | $24,999,967 | $24,999,967 | Equity Only | 06c | SEC link |
| 2024-10-08 | New | $17,243,350 | $17,243,350 | Equity Only | 06b | SEC link |
| 2022-10-18 | New | $24,999,999 | $24,999,999 | Equity Only | 06c | SEC link |
| 2021-02-16 | New | $24,464,276 | $24,464,276 | Equity Only | 06b | SEC link |
| 2018-01-12 | New | $13,338,000 | $13,338,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Joseph Landolina | Director, Executive |
| Scott Levine | Executive |
| Isaac Miller | Director |